Senderowicz Adrian — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Senderowicz Adrian has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $194K.

Profile

Based on the SEC filing context, Adrian Senderowicz is listed as a director of Puma Biotechnology, Inc. as of the 2026-06-16 filing. Puma Biotechnology is a California-based biopharmaceutical company focused on oncology (notably Neratinib). The filing confirms his board seat but does not provide additional biographical details; there is no further verified public information in this context.

Board memberships

• Puma Biotechnology, Inc.

Awards & honors

• Listed as a director of Puma Biotechnology in SEC filings as of 2026-06-16

Recent Transactions

Companies — Last 90 Days

• PUMA BIOTECHNOLOGY, INC. (PBYI) — 1 filings, last 2026-06-16

Frequently Asked Questions

Who is Senderowicz Adrian?

Based on the SEC filing context, Adrian Senderowicz is listed as a director of Puma Biotechnology, Inc. as of the 2026-06-16 filing. Puma Biotechnology is a California-based biopharmaceutical company focused on oncology (notably Neratinib). The filing confirms his board seat but does not provide additional biographical details; there is no further verified public information in…

How many SEC Form 4 filings has Senderowicz Adrian submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Senderowicz Adrian been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($194K) across all tracked filings.

Where can I see all of Senderowicz Adrian's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week